Molnupiravir, an experimental antiviral drug as a future treatment for COVID-19


  7 กรกฎาคม 2021
เยี่ยมชม :  733    ถูกใจ :  0

Shareslotxoknowledge about health and disease exercise method weight loss tips for good health You can eat delicious food for a long time.
Molnupiravir, new hope, oral pill could help treat COVID-19
Molnupiravir (molnupiravir) is an antiviral oral tablet. Developed for the treatment of influenza by German pharmaceutical company Merck, in collaboration with Ridgeback Biotherapeutics, it has been shown to be effective against the coronavirus. Many species, such as SARS, MERS and COVID-19
When can I start taking Molnupiravir?
The Facebook page, Health Knowledge, by Uthai Pharmacist, states that Molnupiravir is still in the phase 2 human research phase into Phase 3. Preliminary results. It has been found to be used in the 2019 coronavirus family, with less drug use than favipiravir and with fewer side effects. Therefore, we have to wait and see if After completing the experiment can be used to treat COVID-19 Can it be like Favipiravir?
Molnupiravir is currently has the status of an experimental antiviral drug It is undergoing Phase 3 clinical trials in humans and is considering for approval by the US Food and Drug Administration.
Tests show new drug can reduce coronavirus replication Quickly reduce the number of viral infections in humans. reduce the severity of the disease Help prevent the spread of the coronavirus and low side effects in animal experiments when giving this drug to lab animals infected with the coronavirus Can prevent other experimental animals that are in close contact with the virus.